Coronavirus Vaccine: News
'Hypervaccinated' man gets 217 COVID-19 jabs for 'private reasons'
A 'hyper-vaccinated' German man—who received 217 COVID-19 vaccine jabs over 29 months—has been declared free of any side effects.
COVID-19 vaccination boosts cancer treatment efficacy in patients: Study
Since the COVID-19 pandemic broke out in early 2020, its vaccines have become a point of discussion for several reasons.
Punjab: 71 COVID-19 cases reported from Patiala's law university
With 71 fresh COVID-19 cases being reported at the Rajiv Gandhi National University of Law in Punjab's Patiala on Wednesday, the number of positive cases has risen to 86, prompting authorities to declare the campus a containment zone.
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced
Prime Minister Narendra Modi on Saturday addressed the nation to announce that India will expand its nationwide COVID-19 vaccination program to adolescents aged 15-18 years next month.
Pfizer is testing new anti-COVID-19 pill. How does it work?
Biopharmaceutical company Pfizer on Monday said that it has started middle-to-late stage clinical trial of an anti-COVID-19 pill to tackle the disease.
Four more Indian pharma firms expected to start vaccine production
Union Health Minister Mansukh Mandaviya on Tuesday said in Parliament that four more Indian pharma firms are expected to start anti-coronavirus vaccine production by October-November that will accelerate the inoculation drive.
COVID-19 vaccine for children likely next month, says Health Minister
India will likely start administering coronavirus vaccines to children in a matter of weeks, Union Health Minister Mansukh Mandaviya said this morning, news agency ANI reported.
Bharat Biotech ends its Brazil agreement. What went wrong?
Bharat Biotech on Friday announced the termination its agreement with two foreign firms for the supply of COVAXIN to Brazil.
European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds
The European drug regulator on Friday recommended approving Moderna's coronavirus vaccine, called Spikevax, for use in children aged 12-17 years, making it the second vaccine to be authorized for this age group in the region.
Can fully vaccinated people develop long COVID?
Coronavirus vaccines are safe and effective.
Half of Australians under lockdown again as COVID-19 cases surge
Until recently, Australia had been praised for its strict lockdowns, lengthy border closures, and quarantine norms over COVID-19.
No sign of Pfizer, Moderna vaccines in breast milk: Study
Researchers have found no evidence of the presence of Pfizer or Moderna COVID-19 vaccines in breast milk suggesting that mRNA preventives are safe during lactation.
PM Modi asks BJP leaders to counter Opposition on COVID-19
Prime Minister Narendra Modi on Tuesday slammed the Opposition, saying it is "spreading lies" and politicizing the coronavirus pandemic.
Pfizer COVID-19 vaccine induces good immune response against coronavirus variants
Two doses of the Pfizer COVID-19 vaccine induce a "very good" antibody response against the SARS-CoV-2 variants, according to a study on 180 health care workers in Finland.
COVAXIN overall 77.8% effective in Phase-3 trial, says Bharat Biotech
COVAXIN, the coronavirus vaccine developed by India's Bharat Biotech, is overall 77.8 percent effective, the company said in a statement today, sharing the final analysis of its phase three trial data.
Expert panel says no to Covovax's children trials in India
A Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has denied permission to Pune-based Serum Institute of India (SII) for conducting clinical trials of its second COVID-19 vaccine, Covovax, in children.
Take the vaccine or go to jail, says Philippines President
Philippines President Rodrigo Duterte is clearly disappointed with the slow pace of COVID-19 vaccination there.
Bharat Biotech submits COVAXIN phase-3 trial data, review meet today
Bharat Biotech has submitted the phase three clinical trial data for its coronavirus vaccine COVAXIN to the Drugs Controller General of India (DCGI).
COVID-19: India vaccinates record 75 lakh people in a day
More than 75 lakh coronavirus vaccine doses were administered across India until 6 pm today, the highest-ever one-day coverage in the country so far, News18 and NDTV reported.
When will the COVID-19 vaccine for children be ready?
India does not have a coronavirus vaccine for children as yet.
India must increase vaccinations five-fold to reach 100% target: Report
India aims to vaccinate its entire eligible population fully against the deadly COVID-19 by the end of 2021. However, the country would not be able to reach this ambitious target at the current pace of vaccination.
People happy with getting jabs at polling booths: Kejriwal
Delhi Chief Minister Arvind Kejriwal visited a vaccination center on Wednesday, a day after his government launched the Jahan Vote, Wahan Vaccination campaign in the national capital.
COVID-19: J&K village first in India to vaccinate all adults
A remote hamlet in the Bandipora district of Jammu and Kashmir has become the first village in India to vaccinate its entire adult population against the novel coronavirus.
COVID-19: Delhi to vaccinate all above 45 within 4 weeks
Delhi CM Arvind Kejriwal on Monday launched a new mass vaccination drive—called Jahan Vote, Wahan Vaccination—for immunizing everyone above the age of 45 years in the national capital against COVID-19 within the coming four weeks.
Central government to give free vaccines to states: PM Modi
Prime Minister Narendra Modi today addressed the nation, speaking on the COVID-19 situation and the vaccination policy in the country.
COVID-19: India reports 1L new cases, lowest in 61 days
India continues to see an improvement in its COVID-19 situation as the country reported just above one lakh new cases in the past 24 hours.
COVID-19: How long does immunity from vaccine last?
India is carrying out an ambitious inoculation program against the coronavirus, vaccinating lakhs everyday.
India will soon test mixing different COVID-19 vaccines
India may soon begin testing a regimen that mixes two different coronavirus vaccines to assess whether the experiment boosts the immune response against the virus.
Pfizer's vaccine works against B.1.617 variant, firm tells Indian government
Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality.
Third COVID-19 wave could hit in 6-8 months: Expert panel
Experts have both good and bad news to offer.
Scindia: India to have 200 crore vaccine doses by December
BJP's Rajya Sabha member Jyotiraditya Scindia on Sunday said vaccination was the only way to tackle coronavirus, and 200 crore vaccine doses, enough for all, would be made available in India by December.
India may buy 50mn Pfizer COVID-19 vaccine doses: Details here
At a time when India is facing an acute shortage of COVID-19 vaccines, the Centre is in "high-level" discussions with American pharmaceutical giant Pfizer, which is likely to sell 50 million doses of its vaccine in India by the third quarter of this year.
COVID-19: Many states rush to import vaccines amid acute shortage
Facing acute shortage of COVID-19 vaccines amid the raging second wave, at least 10 Indian states have decided to reach out to international vaccine manufacturers to fast-track the inoculation drive.
Chaotic start to vaccination of 18-44 category in Noida
Over 2,600 people between 18-44 years got vaccinated for COVID-19 in Gautam Buddh Nagar on Monday, as the inoculation for the age category officially began in the western Uttar Pradesh district, officials said.
EU regulators start the review of China's Sinovac vaccine: Details
European Union drug regulator announced on Tuesday that it has started a rolling review of China's Sinovac coronavirus vaccine to assess its effectiveness and safety, the first step toward possible approval for use in the 27-nation bloc.
Give priority to Maharashtra in vaccine allocation: Tope to Poonawalla
Maharashtra Health Minister Rajesh Tope on Monday urged Serum Institute of India Chief Executive Officer Adar Poonawalla to give priority to the state in providing its anti-coronavirus vaccine, Covishield, as the government was ready to purchase doses from the Pune-based company.
Delhi doesn't have sufficient vaccine doses for next phase: Jain
Delhi Health Minister Satyendar Jain on Thursday said the city does not have sufficient doses of vaccine for the inoculation of those in the 18-44 age group and orders have been placed with manufacturers for the same.
COVID-19: Those above 18 can register for vaccine from April-28
In a recent development, it has been reported that all Indian citizens aged above 18 years can register for the coronavirus vaccine from April 28.
BJP's Devendra Fadnavis under fire after 22-year-old nephew gets vaccinated
Former Maharashtra Chief Minister and current Leader of Opposition, Devendra Fadnavis, faced the ire of netizens after pictures of his nephew Tanmay Fadnavis, said to be about 22 years old, getting vaccinated surfaced.
We understand India's pharmaceutical requirements: Biden administration
The Biden administration has conveyed to New Delhi that it understands India's pharmaceutical requirements and promised to give the matter due consideration, observing that the current difficulty in the export of critical raw materials needed to manufacture COVID-19 vaccines is mainly due to an Act that forces American companies to prioritize domestic consumption.
India's Serum Institute refunds South Africa for undelivered coronavirus vaccines
Pune-based Serum Institute of India (SII) has fully refunded South Africa for 500,000 undelivered doses of the coronavirus vaccine, reports PTI.
118-year-old woman possibly oldest in India to get COVID-19 vaccine
A woman, whose age according to her Aadhaar Card is 118 years, has received her first dose of the COVID-19 vaccine in the Sagar district of Madhya Pradesh.
Pfizer-BioNTech's coronavirus vaccine being tested on children under 12
American pharma giant Pfizer and German company BioNTech began testing their coronavirus vaccine on children, aged under 12, reports Reuters.
Salman Khan receives his first shot of coronavirus vaccine
Salman Khan is the latest Bollywood star to take the COVID-19 vaccine. He confirmed the news through a tweet posted last evening.
Centenarian gets first COVID-19 shot in Delhi
Sindh-born Kamla Das who turned 100 during the height of the pandemic in Delhi last September, got her first shot of COVID-19 vaccine in Delhi on Thursday, her daughter said.
AstraZeneca's coronavirus vaccine dubbed safe; European countries to resume vaccination
A chunk of European countries, that had earlier stopped using AstraZeneca's coronavirus vaccine over blood clot concerns, will resume the vaccination drive after the jab got the support of the continent's top medical regulator.
Quad Summit: India to manufacture coronavirus vaccines developed by US
The leaders of the Quad countries — the United States, Japan, Australia, and India — will be holding the first-ever summit on Friday and are likely to discuss coronavirus vaccines.
Use of AstraZeneca's coronavirus vaccine suspended in Denmark, Norway, Iceland
Denmark, Norway, and Iceland have temporarily suspended the use of the coronavirus vaccine developed by British-Swedish pharma giant AstraZeneca as several patients developed blood clots after getting the jab.
Over 20 lakh COVID-19 vaccine doses administered in a day
More than 20 lakh people were inoculated against coronavirus on March 8, the highest in a day so far, taking the total number of vaccine doses administered in the country to over 2.3 crore, the Union Health Ministry said on Tuesday.
96-year-old is the oldest to get COVID-19 vaccine in Nagaland
A total of 31,391 people have been administered the COVID-19 vaccine in Nagaland till now, and out of them a 96-year-old beneficiary from Dimapur district is the oldest to be inoculated, a Health Department official said on Tuesday.
Johnson & Johnson's one-shot COVID-19 vaccine highly effective: FDA
Johnson & Johnson's single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released by US regulators that sets the stage for a final decision on a new and easier-to-use shot.
Sanitation worker dies from health complications; son blames COVID-19 vaccine
A 54-year-old sanitation worker died from health complications, days after he was administered a coronavirus vaccine, according to his son.
Biden to announce $4 billion commitment to COVID-19 vaccine-sharing campaign
US President Joe Biden will on Friday announce a massive $4 billion commitment to the global COVID-19 vaccine alliance with the goal of inoculating vulnerable populations and reach those without other options, the White House said.
Pfizer-BioNTech to give EU another 200 million COVID-19 shots
Pfizer and BioNTech, on Wednesday, finalized an agreement to supply the European Union with another 200 million doses of their COVID-19 vaccine.
WHO authorizes AstraZeneca's COVID-19 vaccine for emergency use
The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries as part of a UN-backed program to tame the pandemic.
Oxford University testing COVID-19 vaccine in children
The University of Oxford plans to test its COVID-19 vaccine in children for the first time, becoming the latest vaccine developer to assess whether its coronavirus shot is effective in young people.
COVID-19 vaccination drive: Beneficiaries begin to get second dose
The vaccination drive against COVID-19 picked up the pace on Saturday as many beneficiaries who had received their first shots on day one of the exercise four weeks ago turned up to get their second dose.